Review Article

Identifying patterns in COVID-19: Morbidity, recovery and the aftermath

Vinod Nikhra*

Published: 25 May, 2020 | Volume 4 - Issue 1 | Pages: 056-064

The infectivity and pathogenesis: SARS-CoV-2, the causative agent of Covid-19, involves Angiotensin-converting enzyme 2 (ACE2) receptors on type II alveolar type 2 (AT2) cells in lungs. Apart from, the upper and lower respiratory tracts, the disease affects the gastrointestinal system prominently, as evidenced by the significant GI symptoms, early in the course of the disease. In addition, the virus infects ACE2-bearing cells in other organs including the heart and blood vessels, brain, and kidneys.

Clinical features and morbidity: The clinical spectrum of COVID-19 varies from asymptomatic or pauci-symptomatic presentation to moderate to severe states characterized by respiratory failure necessitating mechanical ventilation and ICU support and those manifesting critical clinical condition with complications like sepsis, septic shock, and multiple organ dysfunction failure. The CT chest is an important tool for early identification of COVID-19 pneumonia as well as for prognostic purposes.

The recovery and residual damage: The recovery and other outcomes vary depending on age and other aspects including sex, comorbidities, and genetic factors. The outlook for older adults, who account for a disproportionate share of critical disease, is unfavorable, and most of those who survive are unlikely to return to their previous level of functioning. The disease affects their long-term health and quality of life as well as brings in propensity for truncated post-disease survival.

COVID-19 aftermath and follow up: The patients discharged from hospital following severe COVID-19, continue to suffer with lingering impact of the disease as well as that of the emergency treatments that saved their life. The post-infection reduced exercise tolerance and other subtle factors, like post viral fatigue syndrome, post-traumatic stress disorder, impaired concentration, delirium, and disturbed sleep-wake cycle often underly the functional impairment. In fact, there is need of step-down care and later a multidisciplinary support involving regular clinical assessment, respiratory review, physiotherapy, nutritional advice, and psychiatric support.

Conclusion: The life after COVID-19: After recovery from the disease, the virus SARS-CoV-2, may persist for uncertain period. In addition, the chance of reinfection cannot be ruled out. The vitamin D supplementation may be helpful. In general, the quality of life (QOL) in ICU survivors improves but remains lower than general population levels, but most of the patients adapt well to their level of self-sufficiency and QOL. Also, the debility due to co-morbidities may further compromise the activity of daily living and QOL issues. The Age and severity of illness appear to be the major predictors of post-discharge physical functioning.

Read Full Article HTML DOI: 10.29328/journal.ijcv.1001016 Cite this Article Read Full Article PDF


ACE2; Acute COVID-19 cardiovascular syndrome; Acute respiratory distress syndrome; COVID-19; Cytokine storm syndrome; SARS-CoV-2


  1. Zhao Y, Zhao Z, Wang Y. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. 2020.
  2. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 7: 11. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32169119
  3. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID‐19 and the possibility of faecal transmission. Alimentary Pharm & Thera. 2020; 51: 843-851. PubMed: https://onlinelibrary.wiley.com/doi/abs/10.1111/apt.15731?af=R
  4. Lamers MM, Beumer J, van der Vaart J, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32358202
  5. Nikhra V. The Trans-zoonotic Virome interface: Measures to balance, control and treat epidemics. Ann Biomed Sci Eng. 2020; 4: 020-027.
  6. Guan WJ, Ni ZY, Hu Y, et al. For the China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382: 1708-1720.
  7. McIntosh K, Hirsch MS, Bloom A. Coronavirus disease 2019 (COVID-19): Epidemiology, virology, clinical features, diagnosis, and prevention. Literature review current through: Mar 2020, last updated: 2020. https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-epidemiology-virology-clinical-features-diagnosis-and-prevention
  8. Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020, PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151416/
  9. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. Intensive Care and Critical Care Medicine. 2020.
  10. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18: 844-847. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32073213
  11. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020; 101623. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32179124
  12. Meng H, Xiong R, He R, Lin W, Hao B, et al. CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China. J Infect. 2020. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32294504
  13. Hani C, Trieu NH, Saab I, S. Dangeard,a S. Bennani, et al. Thoracic imaging COVID-19 pneumonia: A review of typical CT findings and differential diagnosis. Diagnostic and Interventional Imaging. 2020; 101: 263-268. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129663/
  14. Pan F, Ye T, Sun P, Gui S, Liang B. et al. Time Course of Lung Changes on Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19). Radiology. 2020; 295: 715-721. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32053470
  15. Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 Patients. AJR Am J Roentgenol. 2020; 1-7. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32174129
  16. Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients with COVID-19. JAMA. 2020; 323: 1499-1500. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32159735
  17. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32291094
  18. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. NEJM Corres. 2020. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32343504
  19. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020; 45: 230-232. PubMed: https://pubmed.ncbi.nlm.nih.gov/32140732/
  20. Hendren NS, Drazner MH, Bozkurt B, Cooper LT, Jr. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020.
  21. Yu Y, Shu H, Xia J, Shu H, Xia J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Resp Med. 2020; 8: P475-481. PubMed: https://pubmed.ncbi.nlm.nih.gov/32105632/
  22. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. NEJM. 2020. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32227758
  23. Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not?. Crit Care. 24; 154. 2020. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32299472
  24. Maiolo G, Collino F, Vasques F, Rapetti F, Tonetti T, et al. Reclassifying acute respiratory distress syndrome. Am J Respir Crit Care Med. 2018; 197: 1586–1595. https://www.ncbi.nlm.nih.gov/pubmed/29345967
  25. Henrya BM, Lippib G. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports. J Crit Care. 2020. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118619/
  26. Porter DL, Maloney DG. Cytokine release syndrome (CRS). UpToDate. Retrieved from https://www.uptodate.com/contents/cytokine-release-syndrome-crs? 2020.
  27. Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Resp Med Corres. 2020, PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32353251
  28. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18: 844-847. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32073213
  29. Tang N, Huan B, Xing C, Gong J, Li D, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18: 1094–1099. https://www.ncbi.nlm.nih.gov/pubmed/32220112
  30. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020. https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)
  31. Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in Case Fatality Rates (CFR) of COVID19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020; 14: 125–128. https://www.ncbi.nlm.nih.gov/pubmed/32146445
  32. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32320003
  33. Zhou F, Yu T, Du R, Fan G, Liu Y, et al. Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395: 1054–1062. https://www.ncbi.nlm.nih.gov/pubmed/32171076
  34. Perez-Guzman PNP, Daunt A, Mukherjee S. Report 17: Clinical characteristics and predictors of outcomes of hospitalised patients with COVID-19 in a London NHS Trust: a retrospective cohort study. Imperial College COVID-19 response team. 2020.
  35. Vincent JL, Taccone FS. Understanding pathways to death in patients with COVID-19. Lancet Respir Med. 2020; 8: 430-432. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32272081
  36. Harrison DA, Parry GJ, Carpenter JR, Short A, Rowan K. A new risk prediction model for critical care: The Intensive Care National Audit & Research Centre (ICNARC) model. Crit Care Med. 2007; 35: 1091-1098. https://www.ncbi.nlm.nih.gov/pubmed/17334248
  37. Which breathing techniques help with COVID-19? Official Q & A. Medically reviewed by Drugs.com https://www.drugs.com/medical-answers/breathing-techniques-covid-19-3536315/
  38. Harman EM. Ed. Pinsky MR. What are the disadvantages to mechanical ventilation in the treatment of acute respiratory distress syndrome (ARDS)? Drugs & Diseases > Critical Care > Acute Respiratory Distress Syndrome (ARDS) Q&A. 2020. https://www.medscape.com/answers/165139-43338/what-are-the-disadvantages-to-mechanical-ventilation-in-the-treatment-of-acute-respiratory-distress-syndrome-ards.
  39. Mak IWC, Chu CM, Pan PC, Yiu MGC, Chan VL. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry. 2009; 31: 318–326. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19555791
  40. Guidance for stepdown of infection control precautions within hospitals and discharging COVID-19 patients from hospital to home settings. 2020. https://icmanaesthesiacovid-19.org/news/stepdown-of-infection-control-precautions-and-discharging-covid-19-patients-to-home-settings.
  41. Tabah A, Philippart F, Timsit JF, Willems V, Français A, et al. Quality of life in patients aged 80 or over after ICU discharge. Crit Care. 2010; 14: R2. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20064197
  42. Zhou F, Yu T, Du R, Fan G, Liu Y, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 1054-1062, PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32171076
  43. Chen Y, Bai W, Liu B, et al. Re-evaluation of Nucleic Acid Retested Positive Cases in the Recovered COVID-19 Patients: Report from a Designated Transfer Hospital in Chongqing, China. 2020.
  44. Martineau AR, Jolliffe DA, Greenberg L, Greenberg L, Aloia JF, et al. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess. 2019; 356: i6583. PubMed: https://pubmed.ncbi.nlm.nih.gov/28202713/
  45. Ilie PC, Stefanescu S, Smith L. The role of Vitamin D in the prevention of Coronavirus Disease 2019 infection and mortality. Research Squqre. 2020.
  46. Dowdy DW, Eid MP, Sedrakyan A, Mendez-Tellez PA, Pronovost PJ, et al. Quality of life in adult survivors of critical illness: a systematic review of the literature. Intensive Care Med. 2005’ 31: 611-620. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15803303


Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More